Refill patterns of atypical and conventional antipsychotic medications at a national retail pharmacy chain

Psychiatric Services

Volumn 52, Issue 9, 2001, Pages 1248-1250

  Vanelli, M ^a   Burstein, P ^a   Cramer, J ^a  

^a Adheris Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; FLUPHENAZINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PERPHENAZINE; QUETIAPINE; RISPERIDONE; TIOTIXENE; TRIFLUOPERAZINE;

ARTICLE; HUMAN; MAJOR CLINICAL STUDY; OUTPATIENT CARE; PATIENT COMPLIANCE; PHARMACY; PRESCRIPTION; PSYCHOSIS;

ANTIPSYCHOTIC AGENTS; CLOZAPINE; DRUG MONITORING; HUMANS; PATIENT COMPLIANCE; PRESCRIPTIONS, DRUG; UNITED STATES;

EID: 0034839361     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ps.52.9.1248     Document Type: Article

References (6)

1. Practice guidelines for the treatment of patients with schizophrenia
2. Advances in understanding and treating mental illness: Implications for policy
3. Determinants of medication compliance in schizophrenia: Empirical and clinical findings
4. Compliance with medication regimens for psychiatric disorders
5. Microelectronic systems for monitoring and enhancing patient compliance with medication regimens
6. Enhancing medication compliance for people with serious mental illness